From: Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
 | 1st quartile | 2nd quartile | 3rd quartile | 4th quartile | P value |
---|---|---|---|---|---|
Subjects (male/female) | 31(25/6) | 31(20/11) | 31(23/8) | 31(20/11) | Â |
Age (years) | 61.0±1.2 | 66.3±1.4* | 65.9±1.5 | 69.6±1.4** | 0.001 |
Height (cm) | 165.3±1.4 | 158.3±1.4** | 164.6±1.1## | 158.8±1.5**,$ | 0.001 |
Weight (kg) | 68.6±2.4 | 59.6±1.7* | 66.7±2.5 | 60.0±1.7* | 0.003 |
BMI | 24.9±0.7 | 23.7±0.5 | 24.5±0.7 | 23.6±0.5 | 0.366 |
Duration of diabetes mellitus (years) | 12.0±1.4 | 16.9±1.6 | 14.7±1.4 | 15.2±1.4 | 0.142 |
Systolic blood pressure (mmHg) | 127.0±2.6 | 133.6±2.5 | 136.1±4.6 | 140.7±2.6* | 0.029 |
Diastolic blood pressure (mmHg) | 74.7±1.5 | 75.0±1.6 | 74.9±1.7 | 75.7±1.7 | 0.975 |
FMD (%) | 4.0±0.5 | 4.4±0.4 | 4.2±0.4 | 3.0±0.7 | 0.178 |
Mean IMT (mm) | 0.95±0.05 | 1.07±0.06 | 1.13±0.07 | 1.04±0.09 | 0.337 |
HbA1c (NGSP) (%) | 8.0±0.4 | 7.6±0.2 | 7.9±0.2 | 7.4±0.2 | 0.371 |
Total cholesterol (mg/dl) | 192.1±7.7 | 191.6±4.6 | 188.1±6.4 | 192.4±4.7 | 0.953 |
Triglyceride (mg/dl) | 136.6±12.9 | 129.7±12.6 | 120.5±9.0 | 137.1±10.8 | 0.709 |
HDL-Cholesterol (mg/dl) | 47.8±2.3 | 51.4±2.7 | 55.2±2.3 | 51.7±2.3 | 0.210 |
LDL-Cholesterol (mg/dl) | 111.7±7.4 | 113.8±4.3 | 109.0±5.2 | 113.0±5.2 | 0.937 |
Creatinine (mg/dl) | 0.78±0.03 | 0.79±0.03 | 0.81±0.04 | 0.83±0.05 | 0.721 |
eGFR (ml/min/1.73m2) | 79.5±3.7 | 70.0±3.0 | 74.4±4.1 | 69.2±3.4 | 0.159 |
Albuminuria (mg/g creatinine) | 75.4±27.9 | 146.8±37.6 | 173.7±43.6 | 117.4±53.6 | 0.357 |
Adiponectin (μg/ml) | 5.8±0.7 | 8.5±1.1 | 9.0±1.6 | 12.2±1.0** | 0.002 |
Osteocalcin (ng/ml) | 1.6±0.2 | 1.7±0.4 | 1.4±0.2 | 1.9±0.3 | 0.596 |
25-hydroxyvitamin D3 (nmol/l) | 93.1±7.7 | 103.4±7.3 | 93.9±10.1 | 61.9±5.6*,##,$ | 0.002 |
FGF23 (pg/ml) | 32.7±2.8 | 31.3±3.1 | 39.0±4.5 | 34.8±2.2 | 0.370 |
Ca (mg/dl) | 9.3±0.05 | 9.4±0.06 | 9.4±0.07 | 9.3±0.07 | 0.499 |
iP (mg/dl) | 3.6±0.09 | 3.6±0.09 | 3.6±0.08 | 3.5±0.08 | 0.937 |